Download PDF
Horm Metab Res 2015; 47(04): 297-302
DOI: 10.1055/s-0034-1398663
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Short-Term Effect of Gastric Resection on Circulating Levels of Ghrelin, Peptide YY3–36 and Obestatin in Patients with Early Gastric Cancer

T. Y. Jeon
1   Department of Surgery, Pusan National University School of Medicine, Gyeongsangnam-do, South Korea
,
S. Y. Lee
2   Medical Education Unit and Medical Research Institute, Pusan National University School of Medicine, Gyeongsangnam-do, South Korea
3   Family Medicine Clinic and Research Institute of Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Gyeongsangnam-do, South Korea
,
H. H. Kim
4   Department of Laboratory Medicine, Pusan National University Hospital, Busan, South Korea
,
Y. H. Cho
3   Family Medicine Clinic and Research Institute of Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Gyeongsangnam-do, South Korea
,
A. R. Cho
3   Family Medicine Clinic and Research Institute of Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, Gyeongsangnam-do, South Korea
› Author Affiliations
Further Information

Publication History

received 23 April 2014

accepted 12 January 2015

Publication Date:
26 February 2015 (online)

Also available at
    Permissions and Reprints

Abstract

The short-term responses of gut hormones and the compensative interaction during a one-week period after subtotal gastrectomy in early gastric cancer (EGC) patients were assessed. Previous studies have reported gut hormonal changes after Roux-en-Y gastric bypass surgery. Blood samples were collected from 40 patients with EGC preoperatively, at 1 h after gastric resection, and on postoperative day (POD) 1, 3, and 7. Levels of active ghrelin, total ghrelin, obestatin, and PYY3-36 were measured. Total ghrelin level rapidly reached a nadir of 69.1%, while active ghrelin level had increased to 135.5% at 1 h after resection. Then, both returned to preoperative level. On the contrary, active/total ghrelin reached its nadir quickly at 1 h after resection and had returned to the preoperative level by POD 3. The nadir PYY3-36 level was 71.4% on POD 1, followed by a gradual recovery, and had increased to 116.5% by POD 7. The same pattern was observed for obestatin. Active ghrelin/obestatin showed an increase on POD 1 while total ghrelin/obestatin showed a decrease on POD 3. Then, both returned to preoperative level. These results suggest that a rapid interactive compensatory mechanism of gut hormones does exist in the remnant gastrointestinal tract after abrupt changes in the production reservoir in nonobese people.

Key words

ghrelin - peptide YY3-36 - obestatin - stomach - gastrectomy
 

  • References

  • 1 de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am 2013; 42: 219-240
    CrossrefPubMedGoogle Scholar
  • 2 Yada T, Yokoi C, Uemura N. The current state of diagnosis and treatment for early gastric cancer. Diagn Ther Endosc 2013; 241320
    PubMedGoogle Scholar
  • 3 Bradley 3rd EL, Isaacs J, Hersh T, Davidson ED, Millikan W. Nutritional consequences of total gastrectomy. Ann Surg 1975; 182: 415-429
    CrossrefPubMedGoogle Scholar
  • 4 Jeon TY, Lee S, Kim HH, Kim YJ, Son HC, Kim DH, Sim MS. Changes in plasma ghrelin concentration immediately after gastrectomy in patients with early gastric cancer. J Clin Endocrinol Metab 2004; 89: 5392-5296
    CrossrefPubMedGoogle Scholar
  • 5 Jeon TY, Lee S, Kim HH, Kim YJ, Lee JG, Jeong DW, Kim YJ. Long-term changes in gut hormones, appetite and food intake 1 year after subtotal gastrectomy with normal body weight. Eur J Clin Nutr 2010; 64: 826-831
    CrossrefPubMedGoogle Scholar
  • 6 Wang HT, Lu QC, Wang Q, Wang RC, Zhang Y, Chen HL, Qian HX. Role of the duodenum in regulation of plasma ghrelin levels and body mass index after subtotal gastrectomy. World J Gastroenterol 2008; 14: 2425-2429
    CrossrefPubMedGoogle Scholar
  • 7 Shlimun A, Unniappan S. Ghrelin O-acyl transferase: bridging ghrelin and energy homeostasis. Int J Pept 2011; 217957
    PubMedGoogle Scholar
  • 8 Guo ZF, Zheng X, Qin YW, Hu JQ, Chen SP, Zhang Z. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J Clin Endocrinol Metab 2007; 92: 1875-1880
    CrossrefPubMedGoogle Scholar
  • 9 Monteleone P, Serritella C, Martiadis V, Scognamiqlio P, Maj M. Plasma obestatin, ghrelin, and ghrelin/obestatin ratio are increased in underweight patients with anorexia nervosa but not in symptomatic patients with bulimia nervosa. Clin Endocrinol Metab 2008; 93: 4418-4421
    CrossrefPubMedGoogle Scholar
  • 10 Roth CL, Reinehr T, Schernthaner GH, Kopp HP, Kriwanek S, Schernthaner G. Ghrelin and obestatin levels in severely obese women before and after weight loss after Roux-en-Y gastric bypass surgery. Obes Surg 2009; 19: 29-35
    CrossrefPubMedGoogle Scholar
  • 11 Beckman LM, Beckman TR, Earthman CP. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. J Am Diet Assoc 2010; 110: 571-584
    CrossrefPubMedGoogle Scholar
  • 12 Sano T, Aiko T. New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer 2011; 14: 97-100
    CrossrefPubMedGoogle Scholar
  • 13 Beckman LM, Beckman TR, Earthman CP. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. J Am Diet Assoc 2010; 110: 571-584
    CrossrefPubMedGoogle Scholar
  • 14 Malin SK, Samat A, Wolski K, Abood B, Pothier CE, Bhatt DL, Nissen S, Brethauer SA, Schauer PR, Kirwan JP, Kashyap SR. Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy. Int J Obes (Lond) 2014; 38: 364-370
    CrossrefPubMedGoogle Scholar
  • 15 Goitein D, Lederfein D, Tzioni R, Berkenstadt H, Venturero M, Rubin M. Mapping of ghrelin gene expression and cell distribution in the stomach of morbidly obese patients – a possible guide for efficient sleeve gastrectomy construction. Obes Surg 2012; 22: 617-622
    CrossrefPubMedGoogle Scholar
  • 16 Khatib N, Gaidhane S, Gaidhane AM, Khatib M, Simkhada P, Gode D, Zahiruddin QS. Ghrelin: ghrelin as a regulatory Peptide in growth hormone secretion. J Clin Diagn Res 2014; 8: MC13-MC17
    PubMedGoogle Scholar
  • 17 Kim HH, Jeon TY, Park DY, Kim YJ, Lee S, Lee JY, Lee JG, Jeong DW, Yi YH, Cho YH, Im SJ, Bae MJ, Choi EJ. Differential Expression of Ghrelin mRNA According to Anatomical Portions of Human Stomach. Hepatogastroenterology 2012; 59: 2217-2221
    PubMedGoogle Scholar
  • 18 Liu J, Prudom CE, Nass R, Pezzoli SS, Oliveri MC, Johnson ML, Veldhuis P, Gordon DA, Howard AD, Witcher DR, Geysen HM, Gaylinn BD, Thorner MO. Novel ghrelin assays provide evidence for independent regulation of ghrelin acylation and secretion in healthy young men. J Clin Endocrinol Metab 2008; 93: 1980-1987
    CrossrefPubMedGoogle Scholar
  • 19 Jacobsen SH, Olesen SC, Dirksen C, Jørgensen NB, Bojsen-Møller KN, Kielgast U, Worm D, Almdal T, Naver LS, Hvolris LE, Rehfeld JF, Wulff BS, Clausen TR, Hansen DL, Holst JJ, Madsbad S. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects. Obes Surg 2012; 22: 1084-1096
    CrossrefPubMedGoogle Scholar
  • 20 Yousseif A, Emmanuel J, Karra E, Millet Q, Elkalaawy M, Jenkinson AD, Hashemi M, Adamo M, Finer N, Fiennes AG, Withers DJ, Batterham RL. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans. Obes Surg 2014; 24: 241-252
    CrossrefPubMedGoogle Scholar
  • 21 Malin SK, Samat A, Wolski K, Abood B, Pothier CE, Bhatt DL, Nissen S, Brethauer SA, Schauer PR, Kirwan JP, Kashyap SR. Improved acylated ghrelin suppression at 2 years in obese patients with type 2 diabetes: effects of bariatric surgery vs standard medical therapy. Int J Obes (Lond) 2014; 38: 364-370
    CrossrefPubMedGoogle Scholar
  • 22 Haluzíková D, Lacinová Z, Kaválková P, Drápalová J, Křížová J, Bártlová M, Mráz M, Petr T, Vítek L, Kasalický M, Haluzík M. Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects. Obesity (Silver Spring) 2013; 21: 1335-1342
    CrossrefPubMedGoogle Scholar
  • 23 Grönberg M, Tsolakis AV, Magnusson L, Janson ET, Saras J. Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem 2008; 56: 793-801
    CrossrefPubMedGoogle Scholar
  • 24 Lippl F, Erdmann J, Lichter N, Tholl S, Wagenpfeil S, Adam O, Schusdziarra V. Relation of plasma obestatin levels to bmi, gender, age and insulin. Horm Metab Res. 2008; 40: 806-812
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Beasley JM, Ange BA, Anderson CA, Miller Iii ER, Holbrook JT, Appel LJ. Characteristics associated with fasting appetite hormones (obestatin, ghrelin, and leptin). Obesity (Silver Spring) 2009; 17: 349-354
    CrossrefPubMedGoogle Scholar
  • 26 Lippl F, Erdmann J, Lichter N, Tholl S, Wagenpfeil S, Adam O, Schusdziarra V. Relation of plasma obestatin levels to bmi, gender, age and insulin. Horm Metab Res 2008; 40: 806-812
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Nakahara T, Harada T, Yasuhara D, Shimada N, Amitani H, Sakoguchi T, Kamiji MM, Asakawa A, Inui A. Plasma obestatin concentrations are negatively correlated with BMI, insulin resistance index, and plasma leptin concentrations in obesity and anorexia nervosa. Biol Psychiatry 2008; 64: 252-255
    CrossrefPubMedGoogle Scholar
  • 28 Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310: 996-999
    CrossrefPubMedGoogle Scholar
  • 29 Beasley JM, Ange BA, Anderson CA, Miller Iii ER, Holbrook JT, Appel LJ. Characteristics associated with fasting appetite hormones (obestatin, ghrelin, and leptin). Obesity (Silver Spring) 2009; 17: 349-354
    CrossrefPubMedGoogle Scholar
  • 30 Huda MS, Durham BH, Wong SP, Deepak D, Kerrigan D, McCulloch P, Ranganath L, Pinkney J, Wilding JP. Plasma obestatin levels are lower in obese and post-gastrectomy subjects, but do not change in response to a meal. Int J Obes (Lond) 2008; 32: 129-135
    CrossrefPubMedGoogle Scholar
  • 31 Kim S, Lee JH, Heo JS, Kwak MJ, Kim SJ, Sohn YB, Kim SE, Song SY, Choe YH, Baek JW, Rha MY, Oh YJ, Jin DK. Serum obestatin/ghrelin ratio is altered in patients after distal gastrectomy. Dig Surg 2009; 26: 143-148
    CrossrefPubMedGoogle Scholar
  • 32 Vicennati V, Genghini S, De Iasio R, Pasqui F, Pagotto U, Pasguali R. Circulating obestatin levels and the ghrelin/obestatin ratio in obese women. Eur J Endocrinol 2007; 157: 295-301
    CrossrefPubMedGoogle Scholar
  • 33 Yoon H, Kim N, Lee HS, Shin CM, Park YS, Lee DH, Jung HC, Song IS. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter 2011; 16: 382-388
    CrossrefPubMedGoogle Scholar